Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias.

Voynova, Elisaveta; Hawk, Nga; Flomerfelt, Francis A; Telford, William G; Gress, Ronald E; Kanakry, Jennifer A; Kovalovsky, Damian

Voynova, Elisaveta; Hawk, Nga; Flomerfelt, Francis A; Telford, William G; Gress, Ronald E; Kanakry, Jennifer A; Kovalovsky, Damian.

Afiliación

Voynova E; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Hawk N; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Flomerfelt FA; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Telford WG; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Gress RE; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Kanakry JA; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Kovalovsky D; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

Cancers (Basel) ; 14(3)2022 Jan 21.

Article en En | MEDLINE | ID: mdl-35158792

Palabras clave

CAR-NK; CAR-T; CD3; CD5; T-cell lymphoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google